Quality of CBD Product Impacts Epilepsy Treatment

Preliminary results of recent research have shown inferior effectiveness of artisanal or low quality CBD compared to that of pharmaceutical CBD for alleviating epileptic seizures. Well, not all CBD products are equally good for epilepsy treatment… But there's more to it. Some can even be harmful!

Medical marijuana CBD oil that contains low levels of THC safely manages seizures in children who suffer from severe epilepsy with Dravet and Lennox-Gastaut syndrome. 

CBD has been shown to bear results even in patients whose illness didn't respond to more conventional medications.

Yet, being proven to cure epilepsy, not every CBD product is the same. Some of them can even be rather unsafe, especially in the wake of poorly established regulations in the industry.

CBD oil for epilepsy. How CBD oil quality can affect epilepsy treatment

Lack of Regulations Leads to Poor Quality of CBD

CBD products with formulas not endorsed by the FDA are called artisanal. They barely undergo any kind of screening process, which leads to all sorts of quality and the number of components. Very often the quality of these CBD products is quite low; to the point where they are fully unsuitable as a medication to treat epilepsy in children.

Even though ever growing evidence has proven cannabidiol (CBD) to be highly effective with treatment-resistant epilepsy. But the scarcity of regulations for doctors on the right concentration and dosing of this and other marijuana-derived compounds hinder the progress.

CBD Oils without CBD?

As it turns out, many CBD products have little to no cannabidiol. In the research conducted in 2017, about 70% of CBD products had less or more CBD than claimed on the packaging. Some of those products even contained THC.

A study conducted in 2018 found the unsafe synthetic cannabinoid 5F-ADB in CBD liquids for vaping.

What Happened to Children Treated with Low Quality CBD 

A study revealed that pharmaceutical-grade CBD consumed by children with epilepsy yielded in seizure control improvements as well as higher cannabidiol serum levels than patients who used artisanal CBD products. 

The group that used pharmaceutical CBD and the artisanal CBD group were found to averagely have 124 nanograms per milliliter and 31 ng/mL respectively. Very different blood levels of CBD.

Patients who took artisanal cannabidiol had a 70% rise in seizures after a year. At the same time, the group which used prescription CBD had a 39% drop.

It is worth mentioning that a dozen of participants who were treated with pharmaceutical CBD experienced such adverse effects as appetite loss, drowsiness, diarrhea and nausea. Some of these effects made 6 of those individuals halt using CBD.

logo © 2019 cannabis PNG74